Driven by Expertise
We are pioneers in developing a quantitative test to track a clinical marker - the muscle pressure in the trapezius muscle.
Envisioning to be a collaborator for pharmaceutical companies to develop treatment plans and drugs aided by the proprietary data we collect in accordance with the clinical marker.
We plan to develop the test that provides a objective diagnosis for the over 10 million people afflicted with fibromyalgia
Our Product
The patented device will read the muscle pressure using our proprietary algorithm to provide accurate instant readout of diagnosis. The device will be packaged to be easily sterilized and maintained in regards
to needle and saline injections required for measuring muscle pressure in a patient's trapezius.
The revenue plan consists of supplying a consumable product that provides an easy to use digital readout. By providing a disposable element, we lessen the burden of maintenance and sterilization from the doctor’s office while providing a recurring source of revenue.
12 million Americans suffer from Fibromyalgia, but only know their symptoms as chronic pain. Many physicians are unaware or unable to provide a diagnosis of Fibromyalgia.